title: Clinical implications of the 5α-androstanedione pathway for castration-resistant prostate cancer.
authors: Nima
authors: N
authors: Sharifi
mesh_terms: D015096:3-Hydroxysteroid Dehydrogenases / Q000378:metabolism; D000069501:Abiraterone Acetate; D000730:Androstadienes / Q000627:therapeutic use; D015114:Androstenediol / Q000378:metabolism; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D003687:Dehydroepiandrosterone / Q000378:metabolism; D005043:Etiocholanolone / Q000031:analogs & derivatives* / Q000378:metabolism; D006801:Humans; D008297:Male; D009919:Orchiectomy; D011471:Prostatic Neoplasms / Q000188:drug therapy* / Q000378:metabolism*; D011944:Receptors, Androgen / Q000378:metabolism; D013739:Testosterone / Q000097:blood / Q000378:metabolism*
chemical_list: D000730:Androstadienes; D000970:Antineoplastic Agents; D011944:Receptors, Androgen; D013739:Testosterone; D003687:Dehydroepiandrosterone; C006576:androstane-3,17-dione; D015114:Androstenediol; D005043:Etiocholanolone; D015096:3-Hydroxysteroid Dehydrogenases; D000069501:Abiraterone Acetate